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Data from the literature indicate that ICAM-1 molecules
play an important role in keratinocyte interactions with
lymphocytes via the lymphocyte function-associated-1
lymphocyte-adhesion molecule. We examined the role of
b1 integrins in keratinocyte–lymphocyte adhesion under
different activation conditions. Among the b1 integrins
expressed on keratinocytes and lymphocytes detected
by indirect immunofluorescence microscopy and flow
cytofluorometry, primarily the a2 and the a3 subunits on
both cell types were involved in keratinocyte–lymphocyte
adhesion. Moreover, the highest adhesion level was
observed when both cell types were activated by IFN-g
The integrins constitute a large family of cell-surfaceadhesion molecules involved in cell–extracellular matrixand cell–cell interactions that play a key role in epidermismorphogenesis and differentiation. Integrins are heterod-imers consisting of noncovalently associated α and β
subunits (Hynes, 1992; Ruoslahti et al, 1994). Epidermal keratinocytes
express several integrins of the β1 family, including α2β1, a receptor
for collagen and laminin, α3β1, a receptor for laminin and epiligrin,
and α6β1, a laminin receptor (Carter et al, 1990, 1991; Adams and
Watt, 1991). Both α2β1 and α3β1 integrins exhibited a pericellular
distribution on basal and suprabasal keratinocytes (De Luca et al, 1990;
Larjava et al, 1990; Symington et al, 1993). In culture, α2β1 and α3β1
integrins were present on basal-like human keratinocytes and were
involved in cell–extracellular matrix and intercellular adhesion (Carter
et al, 1990, 1991; De Luca et al, 1990; Larjava et al, 1990; Adams and
Watt, 1991; Marchisio et al, 1991; Symington et al, 1993).
Close contact between keratinocytes and T lymphocytes is an
important feature of many inflammatory skin diseases. It has been
demonstrated in established inflammatory dermatosis and in interferon-
gamma (IFN-γ)-treated skin that de novo expression of cell adhesion
molecule-1 (ICAM-1) by epidermal keratinocytes is closely linked to
the appearance of infiltrating T cells (Nickoloff, 1988; Shiohara, 1992).
In vitro, IFN-γ has been identified as an inducer of ICAM-1 expression
on keratinocytes (Nickoloff and Mitra, 1989). T cells adhere to
ICAM-1-expressing keratinocytes specifically via lymphocyte function-
associated-1 (LFA-1)–ICAM-1 complex formation (Dustin et al, 1988;
Nickoloff, 1988; Nickoloff and Mitra, 1989). The β2-integrin LFA-1
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for keratinocytes and phorbol 12-myristate 13-acetate for
lymphocytes, suggesting that the former involved the
protein kinase C pathway. Keratinocyte activation, char-
acterized by the expression of ICAM-1, a decrease of b1
integrins, and the absence of a5b1 integrin, was required
for optimal lymphocyte adhesion. Thus, b1 integrins
remaining at the surface of IFN-g-treated keratinocytes
could be activated by this cytokine, and could synergize
with ICAM-1 and lymphocyte function-associated-1
molecules to consolidate keratinocyte–lymphocyte adhe-
sion. Key words: cell activation/cell–cell adhesion/interferon-
gamma. J Invest Dermatol 111:650–655, 1998
molecule is present in an inactive form on resting T lymphocytes and
can be activated by exposure to phorbol esters, such as phorbol 12-
myristate 13-acetate (PMA) (Figdor et al, 1992; Bruynzeel et al, 1993),
which leads to enhanced ligand binding.
The presence of ICAM-1 has been suggested to be an important
step in the pathogenesis of immunologically mediated skin diseases.
Concerning the integrins of the β1 family, their roles are known in
epidermis morphogenesis, wound healing, and keratinocyte stratifica-
tion (Watt, 1984; Carter et al, 1990). In addition, the β1 integrins are
involved in several steps of normal immune-cell function, including
T cell activation and lymphocyte adhesion to endothelial cells and
extracellular matrix (Hemler, 1990; Springer, 1990). Thus, until now,
the role of β1 integrins has only been reported in lymphocyte adhesion
to the extracellular matrix or to endothelial cells, in keratinocyte
adhesion to the extracellular matrix, and in the interkeratinocyte
adhesion (Carter et al, 1990; Hershkoviz et al, 1993; Stewart et al,
1993; Weitzman et al, 1995), but their potential role in keratinocyte–
lymphocyte adhesion remains to be elucidated. The aim of this study
was to determine whether integrins of the β1 family can influence
keratinocyte–lymphocyte adhesion, and whether β1 integrins indeed
play a role in the adhesion of human lymphocytes to human ker-
atinocytes.
MATERIALS AND METHODS
Materials The cell-culture reagents RPMI 1640, keratinocyte-SFM media,
fetal calf serum, bovine pituitary gland extract, epidermal growth factor,
phosphate-buffered saline (PBS), antibiotics (penicillin, streptomycin, kana-
mycin) and amphotericin B, were purchased from Life Technologies Gibco
(Cergy-Pontoise, France). Neutral protease (Dispase) was from Boehringer
(Meylan, France). Culture Petri dishes, flasks, and 96 well microtiter plates
were from Falcon (Becton Dickinson, Le Pont de Claix, France). Collagen I-
coated dishes were from Corning (Corning City, NJ). LabTek coverslips were
from Miles Scientific (Paris, France). Mouse monoclonal antibodies (MoAb)
directed against the integrin subunits α2 (P1E6 clone), α3 (P1B5 clone), α4
(P4G9 clone), or α5 (P1D6 clone), and anti-β1 integrin were from Oncogene
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Science (Uniondale, NY). The anti-ICAM-1 (LB2 clone) and anti-LFA-1
(L130 clone) were from Camfolio (Becton Dickinson). The rabbit polyclonal
antibody raised against α5β1 was a gift from Dr. K. Yamada (NIH, Bethesda,
MD). Mouse and rabbit preimmune sera were from Dako (Trappes, France).
Goat anti-mouse IgG conjugated to fluorescein, and normal goat serum were
obtained from Biomedical Technologies (Stoughton, MA). [35S]Methionine-
cysteine (sp. act. 43.5 TBq per mmol) and [α-32P]dCTP (sp. act. 46.5 GBq
per mmol) were from Dupont NEN (Orsay, France). IFN-γ was from Jansen
Biochemical (Greel, Belgium). Calcein-AM (Mr 994.87) was purchased from
Molecular Probes (Eugene, OR). A 1 mM stock solution of this acetoxymethyl-
ester was prepared in dimethyl sulfoxide, aliquoted and stored at –20°C, and
diluted in PBS, pH 7.4, containing 1% bovine serum albumin before use.
Protein A-Agarose was from Kem en Tec (Copenhagen, Denmark). All other
reagents were the highest purity grade from Sigma (St. Louis, MO).
Cells and cell culture Normal human T lymphocytes were separated by
cytapheresis from the peripheral blood of healthy volunteer blood-bank platelet
donors (Hoˆpital Saint-Louis, Paris, France) and were isolated by two successive
standard Ficoll/Hypaque density-gradient centrifugations to obtain a degree of
purity of over 95% (Boyum, 1968). After a 1 h incubation in RPMI 1640
supplemented with 10% heat-inactivated fetal calf serum, lymphocytes were
transferred into a new flask containing fresh medium. Cell density was set at
2 3 106 cells per ml before use. When required, lymphocytes were activated
by PMA (10 nM, 48 h) prior to the adhesion assay.
Human foreskin keratinocytes were obtained from skin-biopsy fragments
subjected to enzyme dissociation according to Braut-Boucher et al (1995).
Briefly, the biopsy fragments were first treated with 0.25% Dispase in PBS,
pH 7.4, for 90 min at 37°C, and then exposed to 0.25% trypsin-0.05%
ethylenediamine tetraacetic acid for 20 min at 37°C. Isolated keratinocytes
(2 3 106) in keratinocyte-SFM medium containing epidermal growth factor
and bovine pituitary gland extract were seeded on collagen I-coated Petri
dishes, and cultured at 37°C in a 95% air–5% CO2 humidified atmosphere. For
subculture, keratinocytes were plated on Petri dishes. After 1–5 passages, 200 µl
of keratinocyte suspension containing 2 3 104 cells were deposited into the
wells of 96 well plates, and confluent monolayers, examined before the assay
with an inverted phase microscope Olympus IMT2, were used for the adhesion
assay. When required, keratinocytes were activated with IFN-γ (300 U per ml)
for 48 h before the adhesion assay.
Culture media were supplemented with 1% glutamine (200 mM), antibiotics,
2% penicillin (5000 IU per ml)–streptomycin (5000 µg per ml) and 1%
kanamycin (10,000 IU per ml), and 1% amphotericin B (250 µg per ml). In all
cases, cell viability was assessed by trypan blue dye exclusion test and was always
greater than 95%.
Cell-adhesion assay Keratinocyte–lymphocyte adhesion was allowed to
progress in a microplate assay using calcein-AM-labeled lymphocytes and the
percentage of lymphocytes adhered to the monolayer was calculated as previously
described (Braut-Boucher et al, 1995). Briefly, the cell–cell adhesion assay was
performed on keratinocyte monolayers after discarding the culture medium. A
suspension of calcein-AM-labeled lymphocytes (1 3 105 cells per well) was
added to triplicate wells of each monolayer and the plates were incubated for
90 min at 37°C. Then, nonadherent cells were removed by washing three
times with RPMI 1640 containing 10% fetal calf serum. The fluorescence
emitted by the adherent cells was measured by a microtiter plate reader (Fluostar,
Kontron, Saint-Quentin en Yvelines, France). To assess inhibition of cell–cell
adhesion, normal or IFN-γ-treated keratinocyte monolayers were preincubated
for 30 min with one of the MoAb (diluted 1/100) directed against each of the
various integrin subunits under consideration. Afterwards, the excess MoAb
was removed and the calcein-AM-labeled normal or PMA-treated lymphocytes
were added. The same procedure was used to preincubate lymphocytes with
the corresponding MoAb before their plating on normal or IFN-γ-treated
keratinocyte monolayers. In some experiments, IFN-γ-treated keratinocytes
and/or PMA-treated lymphocytes were preincubated with combined additions
of MoAb: (i) anti-β1 integrin subunits plus anti-ICAM-1 or anti-LFA-1; and
(ii) anti-α2 and anti-α3 integrin subunits.
Integrin analysis Cell-surface expression of integrins was investigated using
indirect immunofluorescence microscopy and flow cytofluorometric analysis.
For indirect immunofluorescence microscopy, the cells were plated on glass
coverslips (LabTek) as previously described (Codogno et al, 1988). Before
labeling, they were washed three times in PBS, pH 7.4, and fixed at room
temperature with PBS containing 3.7% formaldehyde for 15 min. Samples were
washed twice for 15 min in PBS, pH 7.4, containing 50 mM NH4Cl, 20 mM
glycine. After washing with PBS containing 0.2% bovine serum albumin, the
cells were incubated with the appropriate antibody. Cultured keratinocytes
were first incubated with anti-integrin MoAb (diluted 1/100) for 45 min at
room temperature and then with goat anti-mouse IgG coupled to fluorescein
isothiocyanate (diluted 1/50), mounted in glycerol-PBS (9–1) and examined
using an Olympus epifluorescence microscope equipped with an HBO 100 W
mercury vapor lamp epiillumination, and photographed using Ilford HP5 film.
For flow cytofluorometry, cells were suspended in PBS containing 1% bovine
serum albumin and 0.01% NaN3. Cells (4 3 10
5 keratinocytes or 1 3 106
lymphocytes) were incubated for 45 min at 4°C with the mouse MoAb (diluted
1/100) to each integrin subunit and then for a further 15 min period at 4°C
in the presence of goat anti-mouse IgG antibodies conjugated to fluorescein
isothiocyanate. Cells were washed in PBS-1% bovine serum albumin and
subjected to FACS analysis (FACScan, Becton Dickinson). For each sample,
data from 5000 to 10,000 cells were collected. Data are expressed as the mean
fluorescence intensity. Control experiments consisted of omitting the primary
antibody and preincubating the cells with preimmune serum instead of the
specific anti-serum.
The same protocols were used to detect the α5β1 integrin with the polyclonal
antibody raised against it.
In some experiments, the keratinocytes were pretreated with 6 µM cheler-
ythrine for 30 min before the addition of IFN-γ. The cells (1 3 107) were
homogenized in 20 mM Tris-HCl buffer, pH 7.4, containing 250 mM sucrose,
0.1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 10 µg aprotinin
per ml and 10 µg leupeptin per ml, and centrifuged at 800 3 g for 5 min at
4°C. The supernatant was centrifuged at 30,000 3 g for 20 min at 4°C. The
cell pellet containing the membrane fraction and the supernatant containing
the cytoplasmic fraction were separated. The cell membrane fractions were
lyzed in 20 mM Tris-HCl buffer containing 150 mM NaCl, 1 µg aprotinin
per ml, 1 µg pepstatin per ml, 1 µg leupeptin per ml, 1 µg phenylmethylsulfonyl
fluoride per ml, and 1% Triton X-100. The protein contents in the lyzed
membrane and cytoplasmic fractions were quantitated using the bicinchoninic
acid kit assay (Smith et al, 1985) and the same amounts of protein were used
for gel electrophoresis experiments.
cDNA librairies The full-length human α5-cDNA insert (pECE-α5) was
generously provided by Dr. E. Ruoslahti (Cancer Research Foundation, La
Jolla, CA) (Giancotti and Ruoslahti, 1990). The pECE-α5 construct was
generated by first digesting the original vector with the restriction enzymes
NdeI and XbaI from Appligene Oncor (Illkirch, France), filling in the ends with
the Klenow fragment of DNA polymerase I, and religating the shortened
vector. The pECE-α5 construct (2.9 kb) was generated by excising the section
of DNA in the α5 insert between the SalI and XbaI restriction sites. As the
pECE expression vector also contained a SalI site, pECE-α5 was first partially
digested with SalI, filled in with the Klenow fragment of DNA polymerase I,
and blunt-end ligand clones containing only one SalI site within the α5
sequence were then identified by restriction screening. The modified vector
was further digested with SalI and XbaI. Ends of the shortened vector were
filled in with the Klenow fragment of DNA polymerase I and religated. Clones
that expressed the insert-encoded protein were isolated and purified. Additional
screenings were done with DNA fragments from the 59 portion of the previously
isolated 2.4 kb cDNA insert that was used as a probe. The cDNA probe from
human α5 was radiolabeled with [32P]dCTP.
RNA hybridization analysis Total RNA was extracted from 5 3 106
cultured cells by guanidinium thiocyanate-phenol-chloroform procedure
(Chomczynski and Sacchi, 1987). Total cellular RNA samples (10 µg) in 25 µl
of 20 mM 3-(N-morpholino)-propanesulfonic acid, pH 7.0, containing 8 mM
sodium acetate, 1 mM ethylenediamine tetraacetic acid, 50% formamide and
6% formaldehyde, were heated at 65°C for 10 min. Then, 2 µl of loading
solution (50% glycerol, 0.5% bromophenol blue) were added to the samples
which were loaded and electrophoresed in a 0.8% Agarose, 6% formaldehyde
gel, and transferred onto a nylon membrane Hybond-N1 (Amersham, les Ulis,
France) and hybridized with a [32P]-labeled cDNA probe for the α5 integrin
subunit, and then exposed to Kodak XAR film at –80°C using intensifying
screens. RNA in the samples was quantitated using a glyceraldehyde-3-
phosphate-dehydrogenase probe (Fort et al, 1985).
Statistical analysis Data were analyzed using Student’s t test. All statistical
analyses were made with Stat View II for Macintosh.
RESULTS
Lymphocytes adhere to IFNg-treated keratinocytes The kinetics
of cell–cell adhesion were investigated from 30 min to 120 min, and
lymphocyte adhesion to keratinocytes reached a plateau as of 60 min
(data not shown): all the subsequent cell-adhesion experiments were
allowed to proceed for 90 min.
Regardless of the keratinocyte status (unactivated or activated),
normal quiescent lymphocytes were less adherent than PMA-activated
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Figure 1. Human T lymphocyte adhesion to IFN-g-treated keratinocytes
is enhanced. Calcein-AM-labeled control (L) or PMA-treated lymphocytes
(PMA-L) were allowed to adhere to monolayers of untreated keratinocytes (u)
or IFN-γ-treated keratinocytes (j). After 90 min of incubation, adherent
lymphocytes were quantitated as described under Materials and Methods. Each
value is the mean of those obtained from three separate experiments run in
triplicate. **p , 0.02; ***p , 0.001.
Table I. Human lymphocytes expressed b1 integrinsa
% positive lymphocytes
Integrin L PMA-L
α2 32 (109) 52 (98)
α3 26 (104) 50 (105)
α4 56 (106) 66 (111)
α5 86 (124) 91 (136)
β1 26 (104) 50 (98)
β2 25 (103) 58 (99)
aLymphocytes incubated alone (L) or in the presence of PMA (PMA-L) were assayed
for expression of αβ1 or αβ2 integrins. The levels of integrin expression were determined
cytofluorometrically and are expressed as percentages of positive cells as described under
Materials and Methods. Percentages represent the means of three experiments. The specific
fluorescence is given between parentheses. SD did not exceed 10%.
lymphocytes (Fig 1). In addition, resting lymphocytes adhered signific-
antly more poorly to control than IFN-γ-treated keratinocytes.
PMA-treated lymphocytes also exhibited significant differences in
their adhesive capacities depending upon the activation status of the
keratinocytes (Fig 1) attaining a significantly higher level on the IFN-
γ-activated keratinocytes.
Thus, the activation of both keratinocytes and lymphocytes further
increased cell–cell adhesion.
The increased lymphocyte adhesion to IFN-γ-treated keratinocytes
could be partly attributable to the cell-surface expression of ICAM-1,
a ligand for LFA-1 (β2 integrin) present on lymphocytes, that has been
shown to be induced after IFN-γ activation (Nickoloff and Griffiths,
1989; Shiohara, 1992).
Indirect immunofluorescence microscopy and flow cytofluorometric
analysis of IFN-γ-activated keratinocytes confirmed the expression of
ICAM-1 (data not shown). The PMA activation of lymphocytes
enhanced LFA-1 expression (Table I). According to Figdor et al (1992),
LFA-1 on resting T lymphocytes is present in an inactive form and is
activated by PMA, which leads to enhanced ligand binding.
Preincubation of keratinocytes with anti-ICAM-1 antibody incom-
pletely inhibited lymphocyte adhesion to the cell monolayer. The most
marked inhibition (61%) was observed when both keratinocytes and
Figure 2. a2, a3, and b1 integrins are detected at the surface of untreated
(K) and IFN-g-treated keratinocytes (IFN-g-K). The keratinocytes were
first incubated with an anti-integrin MoAb to α2, α3, α5, or β1 subunits or
with the polyclonal antibody raised against the α5β1 integrin, as described
under Materials and Methods. Scale bar: 20 µm.
lymphocytes were activated, respectively, with IFN-γ and PMA.
Preincubation of lymphocytes with anti-LFA-1 antibody inhibited
lymphocyte adhesion to keratinocytes by 50%.
These results indicate that lymphocyte adhesion to keratinocytes
was primarily, but not exclusively, attributable to ICAM-1 on ker-
atinocytes and LFA-1 on lymphocytes, respectively, and suggest that
other adhesion molecules could be involved.
b1 integrins are involved in lymphocyte adhesion to
keratinocytes Although both cell types express β1 integrins (Hemler,
1990; Adams and Watt, 1991), their potential role in the keratinocyte–
lymphocyte interaction remains to be demonstrated. The expression
of β1-integrin family molecules and their roles in keratinocyte–
lymphocyte interactions were investigated here under different in vitro
conditions.
Indirect immunofluorescence microscopy detected the presence of
α2, α3, and β1 subunits at the surface of untreated and IFN-γ-treated
keratinocytes (Fig 2). The α5 subunit was detected only on untreated
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Figure 3. IFN-g treatment modifies b1-integrin subunit expression on
keratinocytes. Integrins were detected by flow cytofluorometry with MoAb
to the various integrin subunits. Unshaded portions indicate the shift of
fluorescence intensity after binding and detection of antibodies to α2, α3, α5,
or β1 subunits, or the polyclonal antibody raised against α5β1. K, untreated
keratinocytes; IFN-γ-K, IFN-γ-treated keratinocytes.
keratinocytes (Fig 2). These results were confirmed by flow cyto-
fluorometry, which showed that the keratinocyte monolayer expressed
high levels of α2 and α3 subunits, and less α5. IFN-γ-treated
keratinocytes expressed less α2, α3, and β1 subunits, and α5 subunit
was no longer detectable (Fig 3).
To determine the respective roles of the different β1-integrin
subunits present on keratinocytes in the latters’ interaction with
lymphocytes, the effects of various MoAb on the lymphocyte adhesion
to keratinocytes were evaluated. For this purpose, keratinocytes or
lymphocytes were preincubated with the appropriate MoAb before
the cell–cell adhesion assay.
The addition of anti-α2 subunit MoAb to normal keratinocytes
prior to the adhesion assay equally inhibited the adhesion of untreated
and PMA-treated lymphocytes (Table II). This inhibition induced by
anti-α2 subunit MoAb was more important when keratinocytes were
treated with IFN-γ, regardless of the activation status of the lympho-
cytes. Comparable inhibitions were obtained using MoAb directed
against the α3 subunit. In contrast, MoAb to α5 subunit had no
significant inhibitory effect on keratinocyte–lymphocyte adhesion, in
agreement with indirect immunofluorescence and flow cytometry
experiments using cultured keratinocytes. Only preincubation with
anti-β1 had markedly different inhibitory effects on the two keratino-
cyte substrata, with IFN-γ-treated cells being much more strongly
inhibited.
It has previously been reported that resting as well as activated
Table II. Keratinocyte–lymphocyte adhesion is inhibited by
MoAb directed against b1-integrin subunitsa
Kb IFN-γ-Kb Lc PMA-Lc
MoAb L (%) PMA-L (%) L (%) PMA-L (%) K (%) K (%)
anti-α2 68 71 60 58 89 65
anti-α3 78 77 70 63 89 54
anti-α5 88 83 90 94 90 90
anti-β1 90 89 60 70 32 41
anti-α4 ND ND ND ND 88 88
aHuman keratinocytes or lymphocytes were preincubated with the indicated MoAb
prior to the cell-adhesion assay as described under Materials and Methods. Each value is the
mean of those obtained from three separate experiments run in triplicate, and SD did not
exceed 10%. The amount of adherent lymphocytes was quantitated as described in Materials
and Methods. The adhesion in the presence of MoAb is expressed as the percentage relative
to the adhesion of untreated or PMA-treated lymphocytes on untreated or IFN-γ-treated
keratinocytes in the absence of the MoAb (arbitrarily set at 100% for each case).
bMonolayers of keratinocytes (activated or not) were preincubated with the indicated
anti-integrin MoAb prior to the deposition of the appropriate lymphocyte population.
cLymphocytes were incubated with the indicated MoAb prior to their deposition on
normal keratinocyte monolayers for the adhesion assay. ND, not done.
T lymphocytes expressed low but detectable levels of α3β1, and easily
measurable levels of α4β1 and α5β1, and that in vitro activation of
lymphocytes resulted in distinct changes in the expression of β1
integrins, enhancing α2β1 and α5β1 (Hemler, 1990; Stewart et al,
1993). These integrins are implicated in T cell functions. Therefore,
we attempted MoAb blockage of the various integrin subunits expressed
on normal and PMA-treated lymphocytes to evaluate their respective
contributions to keratinocyte–lymphocyte adhesion. Incubation of
normal lymphocytes with MoAb to α2 or α3 subunit prior to contact
with keratinocyte monolayers had no significant influence on cell–cell
adhesion (Table II). This observation is in agreement with the weak
level of α2 or α3 subunit at the surface of quiescent lymphocytes. In
contrast, preincubation of PMA-activated lymphocytes with either of
these MoAb strongly inhibited their interaction with keratinocytes. As
for keratinocytes, prior incubation of both lymphocyte populations
with anti-α5 had no notable impact on cell–cell adhesion. Although
the α4 subunit was strongly expressed on both quiescent and PMA-
activated lymphocytes, it too was only slightly involved in lymphocyte
adhesion to keratinocytes as shown by the weak inhibition induced by
the MoAb to the α4 subunit. Thus, the α5 and α4 subunits on
lymphocytes did not play a major role in keratinocyte–lymphocyte
adhesion. Comparable percentages of inhibition were obtained when
normal or activated lymphocytes were preincubated with the various
MoAb and then deposited on IFN-γ-treated keratinocytes (data not
shown).
Thus, these results taken together indicated that the β1-integrin
subunits predominantly involved in keratinocyte–lymphocyte adhesion
were the α2 and α3 subunits on both cell types, and suggested possible
homophilic and/or heterophilic interactions. The preincubation of
both IFN-γ-treated keratinocytes and PMA-treated lymphocytes with
anti-α2 and anti-α3 subunits induced a more marked inhibition of
cell–cell adhesion that reached 57%. Moreover, the results of combined
additions of MoAb anti-ICAM-1 plus anti-α2, -α3, or -β1 to IFN-
γ-treated keratinocytes confirmed the contribution of the β1 integrins
to ICAM-1 in keratinocyte–lymphocyte adhesion, because such prein-
cubation reduced cell–cell interactions by 75% vs 61% for anti-ICAM-
1 alone. Similarly, combined additions of MoAb anti-LFA-1 plus anti-
α2, -α3, or -β1 to PMA-treated lymphocytes reduced the keratinocyte–
lymphocyte adhesion by 60% vs 50% for anti-LFA-1 alone.
a5b1-integrin expression reflects the keratinocyte activation
state The α5β1 integrin is strongly expressed in the membrane
fraction of untreated keratinocytes and only weakly detected in that
of IFN-γ-treated keratinocytes. Similar trends were observed in the
cytoplasmic fractions (Fig 4). These findings confirmed the immuno-
fluorescence microscopy and cytofluorometry data (Figs 2, 3). It has
been shown that the keratinocyte differentiation induced by IFN-γ
involved signaling of the protein kinase C (PKC) pathway (Nickolson
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Figure 4. IFN-g treatment decreases a5b1 integrin in the membrane
(mb) and cytoplasmic (cyt) fractions of keratinocytes. The untreated (K)
and IFN-γ-treated keratinocytes (IFN-γ-K) pre-exposed or not to chelerythrine
were processed as described under Materials and Methods before gel electrophoresis
and transfer onto a nitrocellulose membrane. The nitrocellulose sheet was
incubated with the polyclonal antibody raised against α5β1 integrin, and then
with a second antibody coupled to peroxidase. Integrin expression was visualized
by chemoluminescence. (a, d) K; (b, e) IFN-γ-K; (c, f ) IFN-γ-K pre-exposed
to chelerythrine.
Figure 5. IFN-g treatment of keratinocytes leads to a marked decrease
of the mRNA coding for a5 subunit. Total RNA was extracted from
untreated keratinocytes (K) and IFN-γ-treated keratinocytes (IFN-γ-K) pre-
exposed or not to chelerythrine. Northern blots were hybridized with human
α5 cDNA as described under Materials and Methods. In control experiments,
the same RNA samples were hybridized to a [32P]dCTP-labeled probe
(glyceraldehyde-3-phosphate-dehydrogenase). (a) K; (b) IFN-γ-K pre-exposed
to chelerythrine; (c) IFN-γ-K.
and Watt, 1991). When the keratinocytes were exposed to cheler-
ythrine, a PKC inhibitor, before IFN-γ treatment, the intracellular and
the membrane expressions of the α5β1 integrin were comparable with
those detected in untreated keratinocytes (Fig 4). These observations
indicate that the 30 min pretreatment with chelerythrine prior to IFN-
γ activation of keratinocytes prevented the decrease of α5β1 cell-
surface expression induced by IFN-γ (Fig 4). The consequences of
this modulation of the level of α5β1 surface expression were studied
in the lymphocyte–keratinocyte adhesion assay. Only 17% of untreated
and 21% of PMA-treated lymphocytes adhered to the chelerythrine-
treated IFN-γ-activated keratinocytes that expressed ICAM-1 (data not
shown); these values are similar to those of lymphocyte adhesion to
unactivated keratinocytes. Thus, the presence of α5β1 interfered with
the keratinocyte–lymphocyte adhesion mediated by ICAM-1 and LFA-
1. These results pointed out the importance of the activation state of
the keratinocytes, and suggested that this activation induced by IFN-
γ involved the PKC pathway.
Northern blotting showed that IFN-γ stimulation of keratinocytes
led to a marked decrease of the mRNA coding for the α5 subunit
(Fig 5). In accordance with Adams and Watt (1990) and Hotchin et al
(1995), and the pretreatment of keratinocytes with chelerythrine before
IFN-γ activation prevented this decrease (Fig 5). Unlike ICAM-1
present on activated keratinocytes, α5 is present only on untreated
keratinocytes, thereby suggesting that IFN-γ concomitantly modulated
the differentiation of keratinocytes and the expression of the α5β1
integrin.
DISCUSSION
The results obtained in this study showed that ICAM-1 expression
alone on IFN-γ-activated keratinocytes was not sufficient to explain
their interaction with PMA-activated lymphocytes, although ICAM-
1 is required for the adhesion of LFA-1-positive T lymphocytes to the
epidermis (Nickoloff, 1986). We demonstrated that integrins of the β1
family expressed on both cell types influenced keratinocyte–lymphocyte
adhesion. Until now, the role of β1 integrins has only been reported
in lymphocyte adhesion to the extracellular matrix or to endothelial
cells, and in keratinocyte adhesion to the extracellular matrix and
interkeratinocyte adhesion (Carter et al, 1990; Stewart et al, 1993).
The observed increase of surface ICAM-1 expression on IFN-γ-
activated keratinocytes seems to reflect the high level of adhesion of
PMA-activated lymphocytes; however, this correlation was not
observed for β1 integrins because IFN-γ treatment induced a decrease
of β1 integrin expression in parallel with the enhanced percentage of
keratinocyte–lymphocyte adhesion. Thus, rather than the change of
the β1 integrin levels, more subtle changes (conformational, affinity)
could explain their role in cell–cell adhesion, as was previously reported
by Arroyo et al (1995) in the cell–extracellular matrix adhesion. The
IFN-γ-induced modulation of β1 integrin affinity on keratinocytes
could stimulate T lymphocyte migration and initiate adhesion.
Here, using an inhibition assay of cell–cell adhesion, we observed
that the α2 and α3 subunits expressed on keratinocytes were involved
in lymphocyte adhesion and, when the keratinocytes were activated
with IFN-γ, that these β1-integrin subunits were more strongly
implicated. Among the α subunits of the β1 integrins expressed on
lymphocytes, we noted that α2 and α3 were involved in the adhesion
to keratinocytes. Although α5 is known to mediate lymphocyte
adhesion to fibronectin and α4 is implicated in their adhesion to the
endothelial cells, these subunits did not play a major role in ker-
atinocyte–lymphocyte adhesion.
The abilities of MoAb directed against α2 and α3 subunits expressed
on both keratinocytes and lymphocytes to inhibit adhesion of these
cell populations, suggested possible homophilic α2β1–α2β1 or α3β1–
α3β1 integrin interactions and/or heterophilic interactions between
the α2β1 and α3β1 integrins on both keratinocytes and lymphocytes.
This hypothesis is supported by our results because the preincubation
of both keratinocytes and lymphocytes with anti-α2 and anti-α3
subunits induced a more marked inhibition of cell–cell adhesion. Such
interactions have been reported for interkeratinocyte and interfibroblast
adhesions (Sriramarao et al, 1993; Symington et al, 1993; Takeuchi
et al, 1994).
Furthermore, the keratinocyte–lymphocyte adhesive capacity
depended on the activation state of these two cell types. Keratinocyte
activation with IFN-γ is marked by the induction of ICAM-1 expres-
sion, and we observed here that this activation was characterized by
decreased β1-integrin expression and loss of the α5 subunit from the
keratinocyte surface. Similarly, the in vivo differentiation of keratinocytes
from basal to cornified layers reflects the diminution of the β1 integrins
and particularly the absence of α5β1 integrin at the cell surface (Adams
and Watt, 1990, 1991). We noted a relationship between the decreased
relative abundance of the α5β1 integrin at the surface of IFN-γ-treated
keratinocytes and the decreased capacity of keratinocytes to adhere to
fibronectin (M. Boukhelifa, personal communication), in agreement
with the results obtained by Nickolson and Watt (1991) with the
differentiated keratinocytes. Bauvois et al (1996) reported similar results
with monocytes. In addition, it has been shown that the loss of α5β1
receptors from the cell surface of differentiated epidermal keratinocytes
results from the inhibition of α5 and β1 gene transcription (Hotchin
et al, 1992). Moreover, when the IFN-γ effect on keratinocytes was
prevented by chelerythrine, an inhibitor of PKC, the adhesion of
lymphocytes was the same as that observed on untreated keratinocytes.
Thus, it can be concluded that IFN-γ leads to keratinocyte activation
involving the PKC pathway and that this activation is required for
lymphocyte adhesion.
Also, we observed that IFN-γ treatment decreased β1-integrin
subunit expression at the keratinocyte surface; however, the β1 subunits
remaining at the surface of IFN-γ-treated keratinocytes, and which
were associated with the α2 and/or the α3 subunits, could be activated
by this cytokine, thus explaining their contribution to keratinocyte–
lymphocyte adhesion. Finally, as supported by the effects of combined
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additions of MoAb, β1 integrins could synergize with ICAM-1 and
LFA-1 to consolidate keratinocyte–lymphocyte adhesion.
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